| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Sa | Lumentum Holdings (LITE) Soars 15% on PT Hike Ahead of Earnings | ||
| Sa | Natural Gas Services Group (NGS) is one of the New Dividend Paying Companies | ||
| Sa | Fluence Energy (FLNC) Climbs 14% Ahead of Earnings | ||
| Sa | 11 Best Small Cap Tech Stocks to Invest In Now | ||
| Sa | 10 Best Undervalued Stocks to Buy Under $10 | ||
| Fr | Gurhan Kiziloz's Bold Comeback: From Bankruptcy to $1.7 Billion Net Worth | ||
| Fr | Truist Maintains Buy Rating on DLocal (DLO) Expecting Solid Q4 Performance Despite Challenging Volume Comparisons | ||
| Fr | Goldman Sachs Ups Zeta Global (ZETA) PT to $26, Anticipates Software-Sector M&A Surge, Strategic Synergies in 2026 | ||
| Fr | Rosenblatt Initiates Credo Tech (CRDO) With Neutral Rating, $170 PT | ||
| Fr | Guggenheim More Than Doubles Erasca (ERAS) PT Following Clinical Progress and Updated Pipeline Models | ||
| Fr | Chardan Highlights Alumis's (ALMS) Potential After Envudeucitinib Hits All Phase 3 Endpoints in Psoriasis Trials | ||
| Fr | Here's Why Giverny Capital Asset Management Sold Fiserv (FISV) in 2025 | ||
| Fr | Giverny Capital Asset Management Exited Its Long-Term Holding CarMax (KMX) in 2025 | ||
| Fr | Here's Why Giverny Capital Asset Management Sold Align Technology (ALGN) | ||
| Fr | CIBC Reaffirms Thomson Reuters (TRI) Outperform Rating Amid Strategic AI Expansion | ||
| Fr | Susquehanna Sees Over $1B Annual Royalties From Arm's (ARM) AI XPU | ||
| Fr | Citizens Highlights Zscaler's (ZS) Competitive Moat in Cybersecurity | ||
| Fr | KeyBanc Maintains Sector Weight on Charter (CHTR) Amid Rising Broadband Competition | ||
| Fr | TD Cowen Lowers Atlassian (TEAM) Target but Sees Constructive Signals | ||
| Fr | 10 Best American Oil and Gas Stocks to Buy | ||
| Fr | Jim Cramer Discussed Trump, CEOs & These 10 Stocks | ||
| Fr | Freedom Capital Lowers Li Auto (LI) Price Target Amid China EV Price War | ||
| Fr | BofA Reaffirms Buy on Hesai Group (HSAI) Amid New Chips, L3 Regulation, and Growth Drivers | ||
| Fr | UBS Sees Zai Lab (ZLAB) as a Rising Global Biopharma Platform | ||
| Fr | Macquarie Lowers XPeng (XPEV) Target as Subsidy Cuts Weigh on Outlook |